Results 51 to 60 of about 40,598 (248)

Mycotic Diseases in Chelonians

open access: yesJournal of Fungi, 2023
Turtles and ‘tortoises’ populations are declining in number, the factors driving extinction risks being related to habitat loss and degradation, climate change, introduction of invasive plant and animal species, consumption by humans for food and ...
Simona Nardoni, Francesca Mancianti
doaj   +1 more source

AIDS-Related Mycoses: Current Progress in the Field and Future Priorities. [PDF]

open access: yes, 2017
Opportunistic fungal infections continue to take an unacceptably heavy toll on the most disadvantaged living with HIV-AIDS, and are a major driver for HIV-related deaths. At the second EMBO Workshop on AIDS-Related Mycoses, clinicians and scientists from
Armstrong-James, D   +6 more
core   +2 more sources

An outbreak of cutaneous abscesses caused by Panton-Valentine leukocidin-producing methicillin-susceptible Staphylococcus aureus among gold mine workers, South Africa, November 2017 to March 2018

open access: yesBMC Infectious Diseases, 2020
Background We aimed to describe an outbreak of cutaneous abscesses caused by Panton-Valentine leukocidin (PVL)-producing methicillin-susceptible Staphylococcus aureus (MSSA) among gold mine workers. Methods In February 2018, we retrospectively reviewed a
Husna Ismail   +21 more
doaj   +1 more source

A randomized controlled trial evaluating the efficacy and safety of a MYCOFUNGI CREAM in patients with skin mycoses

open access: yesJournal of Pre-Clinical and Clinical Research, 2022
Introduction and objective Skin mycoses is a neglected condition with low quality of life and morbidity that primarily affects school-aged children in developing nations.
Roger Ducos Youmsi Fokouo   +9 more
doaj   +1 more source

Mycotic infections in rheumatology

open access: yesСовременная ревматология, 2017
Invasive mycoses are becoming a more relevant problem in modern rheumatology. There are difficulties in the lifetime diagnosis and treatment of mycoses in patients with rheumatic diseases.
B. S. Belov   +2 more
doaj   +1 more source

Ibrexafungerp: A First-in-Class Oral Triterpenoid Glucan Synthase Inhibitor

open access: yesJournal of Fungi, 2021
Ibrexafungerp (formerly SCY-078 or MK-3118) is a first-in-class triterpenoid antifungal or “fungerp” that inhibits biosynthesis of β-(1,3)-D-glucan in the fungal cell wall, a mechanism of action similar to that of echinocandins.
Sabelle Jallow, Nelesh P. Govender
doaj   +1 more source

Chronic dermatomycoses of the foot as risk factors for acute bacterial cellulitis of the leg: A case-control study [PDF]

open access: yes, 2004
Objective: To assess the role of foot dermatomycosis ( tinea pedis and onychomycosis) and other candidate risk factors in the development of acute bacterial cellulitis of the leg.
Bardur Sigurgeirsson   +13 more
core   +1 more source

Determination of itraconazole and hydroxyitraconazole in plasma by use of liquid chromatography-tandem mass spectrometry with on-line solid-phase extraction [PDF]

open access: yes, 2003
In this paper a method for the simultaneous quantification of the anti-fungal drug itraconazole and its co-active metabolite hydroxyitraconazole in plasma employing liquid chromatography tandem-mass spectrometry and automated solid-phase extraction is ...
Schiel, Xaver   +2 more
core   +1 more source

The epidemiological and mycological profile of superficial mycoses in india from 2015 to 2021: A systematic review

open access: yesIndian Journal of Public Health, 2023
Background: The epidemiological and mycological patterns of superficial mycoses across various geographic regions of India across the last few years are changing. Objective: This study was performed to evaluate the epidemiological and mycological profile
Saibal Das   +3 more
doaj   +1 more source

Impact of glucuronide interferences on therapeutic drug monitoring of posaconazole by tandem mass spectrometry [PDF]

open access: yes, 2010
Background: Posaconazole is a novel antifungal drug for oral application intended especially for therapy of invasive mycoses. Due to variable gastrointestinal absorption, adverse side effects, and suspected drug-drug interactions, therapeutic drug ...
Burghardt, Stephan   +4 more
core   +1 more source

Home - About - Disclaimer - Privacy